CompletedPhase 2NCT00939484
Vismodegib in Treating Patients With Recurrent or Refractory Medulloblastoma
Studying Medulloblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Amar Gajjar, MDPediatric Brain Tumor Consortium
- Intervention
- Pharmacological Study(other)
- Enrollment
- 31 enrolled
- Eligibility
- 22 years · All sexes
- Timeline
- 2009 – 2015
Study locations (13)
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States
- UCSF Medical Center-Mount Zion, San Francisco, California, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
- Pediatric Brain Tumor Consortium, Memphis, Tennessee, United States
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
- Baylor College of Medicine, Houston, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00939484 on ClinicalTrials.govOther trials for Medulloblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07085325CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal IrradiationSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT06701812Digoxin Medulloblastoma StudyH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNANCT06898684Medulloblastoma Online Video-based Exercise Pilot StudyAron Onerup
- RECRUITINGNCT07242963Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyMohammad H. Abu Arja
- RECRUITINGEARLY PHASE1NCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- ACTIVE NOT RECRUITINGPHASE1NCT06514898Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With MedulloblastomaUniversity of Florida
- RECRUITINGNCT06779487Systemic Biomarkers to Predict Radiation-Induced Neurocognitive DeclineTata Memorial Centre
- RECRUITINGEARLY PHASE1NCT06959979Novel Molecular Targets and Innovative Therapeutic Perspective in MedulloblastomaFondazione Policlinico Universitario Agostino Gemelli IRCCS